Acrylamide and glycidamide hemoglobin adducts and epithelial ovarian cancer: a nested case-control study in non-smoking postmenopausal women from the EPIC cohort.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, no. 1 (2016): 127.0-134.0
Background: Acrylamide was classified as "probably carcinogenic to humans (group 2A)" by the International Agency for Research on Cancer. Epithelial ovarian cancer (EOC) is the fourth cause of cancer mortality in women. Five epidemiological studies have evaluated the association between EOC risk and dietary acrylamide intake assessed usin...More
Get fulltext within 24h
Full Text (Upload PDF)
PPT (Upload PPT)